Zobrazeno 1 - 10
of 164
pro vyhledávání: '"N, Chauret"'
Publikováno v:
B69. AIRWAY INJURY AND REPAIR: MECHANISMS AND TREATMENT.
Autor:
Peter V. Dicpinigaitis, M. Blaiss, K.J. Carroll, J.E. Shaw, C.M. Bonuccelli, D. Garceau, M.R. Sher, N. Chauret, L. Harvey, M. Garin, Surinder S. Birring, Jacky Smith
Publikováno v:
TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA.
Publikováno v:
C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS.
Publikováno v:
Journal of Investigative Dermatology. 139:S232
Autor:
N Chauret, J Archambault
Publikováno v:
Analytica Chimica Acta. 249:231-234
The detection by fluorimetry after liquid chromatographic (LC) separation of benzophenanthridine alkaloids extracted from Papaveraceae sp. cell culture samples was characterized and optimized. Maximum fluorescence was observed at 225 nm excitation an
Autor:
N, Chauret, B, Dobbs, R L, Lackman, K, Bateman, D A, Nicoll-Griffith, D M, Stresser, J M, Ackermann, S D, Turner, V P, Miller, C L, Crespi
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(9)
Recently, a novel nonfluorescent probe 3-[2-(N,N-diethyl-N-methylammonium)-ethyl]-7-methoxy-4-methylcoumarin (AMMC), which produces a fluorescent metabolite AMHC (3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-hydroxy-4-methylcoumarin) was used with mic
In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization
Autor:
J A, Yergey, L A, Trimble, J, Silva, N, Chauret, C, Li, M, Therien, E, Grimm, D A, Nicoll-Griffith
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(5)
The metabolic profile of DFU [5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)phenyl-2(5H)-furanone], a potent and selective COX-2 inhibitor, was characterized using in vitro microsomal and hepatocyte incubations. A single product, corresponding
Autor:
C, Li, N, Chauret, L A, Trimble, D A, Nicoll-Griffith, J M, Silva, D, MacDonald, H, Perrier, J A, Yergey, T, Parton, R P, Alexander, G J, Warrellow
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(3)
CDP-840 is a selective and potent phosphodiesterase type IV inhibitor, whose in vitro metabolism profile was first investigated using liver microsomes from different species. At least 10 phase I oxidative metabolites (M1-M10) were detected in the mic
Autor:
D A, Nicoll-Griffith, J M, Silva, N, Chauret, S, Day, Y, Leblanc, P, Roy, J A, Yergey, R, Dixit, D, Patrick
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(2)
The drug candidate DFP [5,5-dimethyl-3-(2-isopropoxy)-4-(4-methanesulfonylphenyl)-2(5H)-furanone] is a selective cyclooxygenase-2 inhibitor under evaluation for analgesic and anti-inflammatory therapy. The in vitro metabolic pathways (rat microsomes)
Publikováno v:
Journal of Hepatology. 50:S341-S342